2014 patient workshops: Register your interest now!
Topic: Pharmaceutical Pricing, Access and Reimbursement

EFNA invites representatives from patient associations to register their interest in upcoming workshops on Pharmaceutical Pricing, Access and Reimbursement at the London School of Economics. This important initiative is aimed at equipping participants with the knowledge and skills they need to be actively involved in influencing regulatory decision-making in relation to medical technologies/pharmaceuticals.

By attending this course, participants will obtain insights on: (a) how pharmaceuticals fit within the overall health care system; (b) how different countries in Europe and beyond pay for pharmaceuticals; (c) what are the most salient regulations addressing coverage/access and how these affect patient access; (d) how stakeholders – including patients – participate in the decision-making process. Topics will include:

• Rate of Return Regulations
• Price Referencing and Tendering
• Patient Access Schemes
• Generic Pharmaceutical Policy
• Risk Sharing
• Adherence to Medicines
• Value Based Pricing
• Prescribing Policies and Incentives

The intensive programme will start at 09.00hrs on the first day and finish at 17.30hrs on Day 2. Costs of the course (including standard class travel (up to £300), accommodation and meals) will be covered by EFNA. Your contribution is your time and effort.

The last course of 2014 is provisionally scheduled to take place in November 2014. Send your name to executivedirector@efna.net to ensure you receive notification when the next course in confirmed.

Criteria for Participants: Participants should have a conceptual understanding of the regulatory process for new medicines/medical technologies. The course content, which is advanced, is suitable only for participants who are already engaging with regulators, payers and decision makers at either a National and/or European level, and/or those who are actively involved in the shaping of policy within their organisation.

Participants must also be fluent in English – allowing them to comprehend the regulatory terminology used throughout the workshop and contribute to the debate/discussion arising.

The number of participants is limited to 30 to ensure that there is ample opportunity for interaction. All participants will leave the course with a certificate from the LSE.

The course is run by Prof. Panos Kanavos of the London School of Economics. Prof. Kanavos is Reader in International Health Policy and is an economist by training. He coordinates the activities of the Medical Technology Research Group at LSE and works closely with the wider stakeholder community (government, patients, industry). His research interests comprise health systems analysis and reform, health technology assessment and the economics of medical technology.